Mukherjee, S.; Sakpal, A.; Mehrotra, M.; Phadte, P.; Rekhi, B.; Ray, P.
Correction: Mukherjee et al. Homo and Heterotypic Cellular Cross-Talk in Epithelial Ovarian Cancer Impart Pro-Tumorigenic Properties through Differential Activation of the Notch3 Pathway. Cancers 2022, 14, 3365. Cancers 2024, 16, 685.
https://doi.org/10.3390/cancers16040685
AMA Style
Mukherjee S, Sakpal A, Mehrotra M, Phadte P, Rekhi B, Ray P.
Correction: Mukherjee et al. Homo and Heterotypic Cellular Cross-Talk in Epithelial Ovarian Cancer Impart Pro-Tumorigenic Properties through Differential Activation of the Notch3 Pathway. Cancers 2022, 14, 3365. Cancers. 2024; 16(4):685.
https://doi.org/10.3390/cancers16040685
Chicago/Turabian Style
Mukherjee, Souvik, Asmita Sakpal, Megha Mehrotra, Pratham Phadte, Bharat Rekhi, and Pritha Ray.
2024. "Correction: Mukherjee et al. Homo and Heterotypic Cellular Cross-Talk in Epithelial Ovarian Cancer Impart Pro-Tumorigenic Properties through Differential Activation of the Notch3 Pathway. Cancers 2022, 14, 3365" Cancers 16, no. 4: 685.
https://doi.org/10.3390/cancers16040685
APA Style
Mukherjee, S., Sakpal, A., Mehrotra, M., Phadte, P., Rekhi, B., & Ray, P.
(2024). Correction: Mukherjee et al. Homo and Heterotypic Cellular Cross-Talk in Epithelial Ovarian Cancer Impart Pro-Tumorigenic Properties through Differential Activation of the Notch3 Pathway. Cancers 2022, 14, 3365. Cancers, 16(4), 685.
https://doi.org/10.3390/cancers16040685
